RG
MDNA
Rathbones Group’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-105,663
| Closed | -$33.8K | – | 648 |
|
|
2023
Q4 | $33.8K | Hold |
105,663
| – | – | ﹤0.01% | 593 |
|
|
2023
Q3 | $31.7K | Hold |
105,663
| – | – | ﹤0.01% | 607 |
|
|
2023
Q2 | $50.7K | Hold |
105,663
| – | – | ﹤0.01% | 402 |
|
|
2023
Q1 | $68.7K | Hold |
105,663
| – | – | ﹤0.01% | 399 |
|
|
2022
Q4 | $49.7K | Hold |
105,663
| – | – | ﹤0.01% | 414 |
|
|
2022
Q3 | $87K | Buy |
105,663
+65,663
| +164% | +$54.1K | ﹤0.01% | 397 |
|
|
2022
Q2 | $46K | Hold |
40,000
| – | – | ﹤0.01% | 420 |
|
|
2022
Q1 | $53K | Hold |
40,000
| – | – | ﹤0.01% | 418 |
|
|
2021
Q4 | $66K | Hold |
40,000
| – | – | ﹤0.01% | 416 |
|
|
2021
Q3 | $110K | Hold |
40,000
| – | – | ﹤0.01% | 407 |
|
|
2021
Q2 | $121K | Hold |
40,000
| – | – | ﹤0.01% | 410 |
|
|
2021
Q1 | $163K | Hold |
40,000
| – | – | ﹤0.01% | 384 |
|
|
2020
Q4 | $187K | Hold |
40,000
| – | – | ﹤0.01% | 367 |
|
|
2020
Q3 | $164K | Buy |
+40,000
| New | +$164K | ﹤0.01% | 352 |
|